ORIC icon

Oric Pharmaceuticals

90 hedge funds and large institutions have $291M invested in Oric Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

18% less capital invested

Capital invested by funds: $353M → $291M (-$62.7M)

24% less call options, than puts

Call options by funds: $216K | Put options by funds: $285K

Holders
90
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$216K
Puts
$285K
Net Calls
Net Calls Change

Top Buyers

1 +$7M
2 +$4.79M
3 +$4.71M
4
Franklin Resources
Franklin Resources
California
+$4.43M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$3.02M

Top Sellers

1 -$3.83M
2 -$3.63M
3 -$1.98M
4
O
OrbiMed
New York
-$1.66M
5
PM
Prosight Management
Texas
-$1.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$25.9M
2
$22.6M
3
$21.6M
4
$21M
5
$20.7M
6
$18.9M
7
$15.7M
8
$15.6M
9
$13M
10
$13M
11
$10.5M
12
$9.98M
13
$7.04M
14
$6.8M
15
$6.1M
16
$5.99M
17
$5.41M
18
$4.96M
19
$4.71M
20
$4.54M
21
$4.35M
22
$3.64M
23
$2.53M
24
$2.33M
25
$2.3M